June 2026: The Pits Are Dead, But The Greed Is Eternal
Market Pulse: June 1, 2026
SPY is grinding to 759.66 and QQQ is pushing 744.35. VIX is up at 15.75, which tells me the guys in the suits are finally nervous about their delta-hedged garbage. The floor is long gone, replaced by algorithms that don't know what a 'bid' is until it hits their execution layer.
| Ticker | Price | Change % | RVOL |
|---|---|---|---|
| $FLNC | 27.92 | +47.88 | 5.1 |
| $TMHC | 71.56 | +22.33 | 14.29 |
| $TWLO | 229.35 | +20.31 | 2.2 |
| $SKM | 44.63 | +19.54 | 3.18 |
| $MGM | 51.41 | +17.75 | 4.33 |
| $NUVL | 96.26 | -12.80 | 3.9 |
The M&A Circus: $MGM and $TMHC
Barry Diller is swinging his checkbook at $MGM, and the retail lemmings are chasing the 17.75% pop like it’s 1999. It’s an arbitrage play gone wrong for the short-sellers who got squeezed out of their positions. Meanwhile, $TMHC is moving on Berkshire talk. When Buffett’s shop pivots to homebuilders, it’s a signal that the 'smart money' is betting on the only thing left: land and bricks. Volume is 14x average. This isn't organic buying; it's a massive institutional re-allocation.
The AI Mirage: $FLNC and $TWLO
$FLNC is up nearly 50% on a Nvidia partnership rumor. It’s the classic 'AI Data Center' narrative. These guys are supply chain cogs, and the street is treating them like they discovered cold fusion. $TWLO is catching a bid because BoA decided to upgrade the profit outlook. It’s all about the 'hidden profit lever' narrative. If you believe there’s a secret button for profit in a SaaS company, I have a bridge in Brooklyn to sell you.
Biotech Bloodletting: $NUVL
$NUVL is down 12.8%. The NDA filing hit, the biotech bros sold the news, and the retail bagholders are left holding the terminal. This is what happens when you trade clinical data instead of order flow.
The Play
Watch the $QQQ gamma levels. If we break 745, the dealers will be forced to buy, pushing us higher into a blow-off top. If we fail, expect a sweep of the 730s. Don't look for logic. Look for the tape. The market doesn't care about your thesis; it cares about your liquidity.
Data Source: Market Close Analysis, June 1, 2026.
Disclaimer: Eachi Alpha provides independent financial analysis based on algorithmic market data. This content is for informational and educational purposes only and does not constitute financial, investment, or trading advice. Trading securities involves significant risk. Eachi Alpha is not responsible for any financial losses or damages resulting from the use of this information. Always perform your own due diligence before making investment decisions.